未登录

Z

Zhiyong Yu

zhe jiang university

H指数:27

被引数:2,970

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Exploring the value of FAP-targeted PET/CT in differentiating breast cancer molecular subtypes: a preliminary study

European Journal of Nuclear Medicine and Molecular Imaging

IF7.6

2024-08-121

PRE

Construction of a risk stratification model integrating ctDNA to predict response and survival in neoadjuvant-treated breast cancer

IF8.3

2023-12-123

OAAI

The HDAC inhibitor HFY-4A improves TUSC2 transcription to induce immunogenic cell death in breast cancer

TOXICOLOGY AND APPLIED PHARMACOLOGY

IF3.4

2023-11-015

PRE

CREB3L2 Regulates Hemidesmosome Formation during Epithelial Sealing

JOURNAL OF DENTAL RESEARCH

IF5.9

2023-08-093

PRE

Real-world treatment patterns and outcomes of pyrotinib-based therapy in patients with HER2-positive advanced breast cancer (PRETTY): A nationwide, prospective, observational study

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2023-08-068

OA

FBXO24 Suppresses Breast Cancer Tumorigenesis by Targeting LSD1 for Ubiquitination

MOLECULAR CANCER RESEARCH

IF4.7

2023-08-044

PRE

Prediction of bone metastasis risk of early breast cancer based on nomogram of clinicopathological characteristics and hematological parameters

FRONTIERS IN ONCOLOGY

IF3.3

2023-07-141

OAAI

Spatial immunophenotypes orchestrate prognosis in triple-negative breast cancer with Miller-Payne grade 4 following neoadjuvant chemotherapy

NPJ BREAST CANCER

IF7.6

2023-07-121

OAAI

Efficacy and safety of inetetamab-containing regimens in patients with HER2-positive metastatic breast cancer: a real-world retrospective study in China

FRONTIERS IN ONCOLOGY

IF3.3

2023-06-194

OAAI

Imaging the metabolic reprograming of fatty acid synthesis pathway enables new diagnostic and therapeutic opportunity for breast cancer

CANCER CELL INTERNATIONAL

IF6

2023-04-292

OAAI

A novel nomogram model of breast cancer-based imaging for predicting the status of axillary lymph nodes after neoadjuvant therapy

一种新的乳腺癌影像学列线图模型预测新辅助治疗后腋窝淋巴结状态

SCIENTIFIC REPORTS

IF3.9

2023-04-123

OAAI

Spatial immunophenotypes contribute to predict survival of triple-negative breast cancer assessed as Miller-Payne grade 4 and N0 after neoadjuvant therapy

CANCER RESEARCH

IF16.6

2023-04-040

PRE

Cyperotundone combined with adriamycin induces apoptosis in MCF-7 and MCF-7/ADR cancer cells by ROS generation and NRF2/ARE signaling pathway

SCIENTIFIC REPORTS

IF3.9

2023-01-2511

OAAI

Selective internal radiation therapy of metastatic breast cancer to the liver: A meta-analysis

FRONTIERS IN ONCOLOGY

IF3.3

2022-11-244

OAAI

Pivotal roles of tumor-draining lymph nodes in the abscopal effects from combined immunotherapy and radiotherapy

肿瘤引流淋巴结在联合免疫疗法和放射疗法的远镜作用中的关键作用

CANCER COMMUNICATIONS

IF24.9

2022-08-1319

OAAI

A Nomogram Based on Hematological Parameters and Clinicopathological Characteristics for Predicting Local-Regional Recurrence After Breast-Conserving Therapy

FRONTIERS IN ONCOLOGY

IF3.3

2022-07-191

OAAI

EBF1 promotes triple-negative breast cancer progression by surveillance of the HIF1α pathway

EBF1通过监测HIF1α 通路促进三阴性乳腺癌进展

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2022-07-089

OAAI

Rab8A promotes breast cancer progression by increasing surface expression of Tropomyosin-related kinase B (vol 535, 215629, 2022)

IF10.1

2022-07-010

PRE

Rab8A promotes breast cancer progression by increasing surface expression of Tropomyosin-related kinase B

IF10.1

2022-06-018

PRE

Treatment patterns and adverse events of pyrotinib-based therapy in HER2-positive breast cancer patients in China: Results from a multicenter, real-world study

CANCER RESEARCH

IF16.6

2022-02-151

PRE